Live Breaking News & Updates on Health science technologies

Stay informed with the latest breaking news from Health science technologies on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Health science technologies and stay connected to the pulse of your community

IDEX (NYSE:IEX) Downgraded to Hold at StockNews.com

StockNews.com lowered shares of IDEX (NYSE:IEX – Free Report) from a buy rating to a hold rating in a research note published on Wednesday morning. A number of other research firms also recently weighed in on IEX. Royal Bank of Canada restated an outperform rating and issued a $255.00 target price on shares of IDEX […]

Canada , Stifel-nicolaus , Company-profile , Health-science-technologies , Royal-bank , Solutions-inc , Edgerock-capital , Citigroup , Visionpoint-advisory-group , Riverview-trust-co , Free-report , Moderate-buy

Decoding IDEX Corp (IEX): A Strategic SWOT Insight

Unveiling the Strengths and Challenges: A Deep Dive into IDEX Corp (IEX) SWOT Analysis

Material-solutions , Market-softness-in-health-science-technologies , Health-science-technologies , Product-innovation , Iridian-spectral-technologies , Cash-flow-generation , Market-presence , Science-technologies , Employee-related-costs , Industrial-activity , Economic-conditions

IDEX (NYSE:IEX) Issues FY 2024 Earnings Guidance

IDEX (NYSE:IEX – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 8.150-8.450 for the period, compared to the consensus EPS estimate of 8.330. The company issued revenue guidance of -. IDEX also updated its FY24 guidance to $8.15-$8.45 EPS. Analysts Set New […]

Canada , Stifel-nicolaus , Robertw-baird , Health-science-technologies , Royal-bank , Company-profile , Citigroup , Get-free-report , Moderate-buy , Metering-technologies , Science-technologies , Diversified-products

IDEX (NYSE:IEX) Issues Q2 2024 Earnings Guidance

IDEX (NYSE:IEX – Get Free Report) updated its second quarter 2024 earnings guidance on Tuesday. The company provided EPS guidance of 2.000-2.050 for the period, compared to the consensus EPS estimate of 2.120. The company issued revenue guidance of -. IDEX also updated its FY 2024 guidance to 8.150-8.450 EPS. Wall Street Analysts Forecast Growth […]

Robertw-baird , Stifel-nicolaus , Health-science-technologies , Company-profile , Citigroup , Get-free-report , Moderate-buy , Metering-technologies , Science-technologies , Diversified-products , Idex , Nyse-iex

IDEX Corporation (NYSE:IEX) Q1 2024 Earnings Call Transcript

Operator: Greetings, and welcome to the IDEX Corporation First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Robertw-baird , Wendy-palacios , Abhi-khandelwal , Mike-halloran , Warren-rupp , Eric-ashleman , Corporation-first-quarter , Exchange-commission , Idex-corporation , Wendy , Health-science-technologies , Financial-security-assurance-inc

IDEX (NYSE:IEX) Releases FY 2024 Earnings Guidance

IDEX (NYSE:IEX – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 8.150-8.450 for the period, compared to the consensus earnings per share estimate of 8.330. The company issued revenue guidance of -. IDEX also updated its FY24 guidance to $8.15-$8.45 EPS. Analyst Ratings Changes […]

Canada , Stifel-nicolaus , Citigroup , Health-science-technologies , Royal-bank , Get-free-report , Moderate-buy , Metering-technologies , Science-technologies , Diversified-products , Idex , Nyse-iex

IDEX (NYSE:IEX) Updates Q2 2024 Earnings Guidance

IDEX (NYSE:IEX – Get Free Report) updated its second quarter 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 2.000-2.050 for the period, compared to the consensus earnings per share estimate of 2.120. The company issued revenue guidance of -. IDEX also updated its FY 2024 guidance to 8.150-8.450 EPS. Wall […]

Canada , Stifel-nicolaus , Citigroup , Company-profile , Health-science-technologies , Royal-bank , Get-free-report , Moderate-buy , Metering-technologies , Science-technologies , Diversified-products , Idex

IDEX (NYSE:IEX) Releases Q2 2024 Earnings Guidance

IDEX (NYSE:IEX – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 2.000-2.050 for the period, compared to the consensus estimate of 2.120. The company issued revenue guidance of -. IDEX also updated its FY 2024 guidance to 8.150-8.450 […]

Canada , Stifel-nicolaus , Royal-bank , Health-science-technologies , Citigroup , Get-free-report , Moderate-buy , Metering-technologies , Science-technologies , Diversified-products ,

IDEX Co. (NYSE:IEX) Receives $238.78 Average Target Price from Brokerages

Shares of IDEX Co. (NYSE:IEX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective […]

Canada , Stifel-nicolaus , Riverview-trust-co , Royal-bank , Visionpoint-advisory-group , Solutions-inc , Citigroup , Health-science-technologies , Edgerock-capital , Get-free-report , Rock-capital , Get-free

Analyzing Key Insights from Idex Corporation (IEX) Quarterly SEC 10-Q Report

Analyzing Key Insights from Idex Corporation (IEX) Quarterly SEC 10-Q Report
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Abhishek-khandelwal , Health-science-technologies , Science-technologies , Performance-indicators , Senior-vice-president , Chief-financial , Private-securities-litigation-reform-act ,